Active	Status	Sponsor type	Region	Phase	Filter
1 Active 17 Inactive 18 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zontivity (vorapaxar) / Merck (MSD)
NCT02629367: Influence of Vorapaxar on Thrombin Generation and Coagulability	Not yet recruiting	4	100	US	Vorapaxar, Asprin, Clopidogrel	Inova Health Care Services	Coronary Artery Disease	01/17	03/17